Did SAVR outcomes suffer due to the rapid rise of TAVR? A team of researchers aimed to find out with a brand new analysis. 

Adam Greenbaum, MD, co-director of the Structural Heart and Valve Center at Emory University Hospital Midtown in Atlanta, explains details from the late-breaking CLASP TR trial at ACC.22.

The new algorithm was designed to evaluate a user's heart rhythm while they are still or even sleeping. 

Several late-breaking clinical trials at ACC.22 will likely impact clinical practice. Below are summaries of a few key trials and their takeaways for interventional cardiology and structural heart interventions. 

A Chinese study of 2.8 million participants found that 94% of users flagged for AFib indeed have the heart rhythm disorder.

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.

Resource-challenged providers in rural areas and elsewhere may not always have access to this technology, given the hefty price tag, experts wrote Monday. 

Based on imaging, researchers suggested that gray matter volume could be a predictive marker of outcomes in mental health disorders, such as depression.